SE405477B - Forfarande for framstellning av tetrazolyl-kinaldinsyraderivat med farmakologisk verkan - Google Patents
Forfarande for framstellning av tetrazolyl-kinaldinsyraderivat med farmakologisk verkanInfo
- Publication number
- SE405477B SE405477B SE7309000A SE7309000A SE405477B SE 405477 B SE405477 B SE 405477B SE 7309000 A SE7309000 A SE 7309000A SE 7309000 A SE7309000 A SE 7309000A SE 405477 B SE405477 B SE 405477B
- Authority
- SE
- Sweden
- Prior art keywords
- kinaldinic
- tetrazolyl
- procedure
- preparation
- acid derivatives
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 230000000144 pharmacologic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Quinoline Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB3099072A GB1383088A (en) | 1972-07-03 | 1972-07-03 | Pharmacologically active quinaldamide derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE405477B true SE405477B (sv) | 1978-12-11 |
Family
ID=10316264
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7309000A SE405477B (sv) | 1972-07-03 | 1973-06-26 | Forfarande for framstellning av tetrazolyl-kinaldinsyraderivat med farmakologisk verkan |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US3932416A (xx) |
| JP (1) | JPS4962486A (xx) |
| AT (1) | AT328449B (xx) |
| AU (1) | AU473752B2 (xx) |
| BE (1) | BE801246A (xx) |
| CH (1) | CH592081A5 (xx) |
| CS (1) | CS193474B2 (xx) |
| DE (1) | DE2332731A1 (xx) |
| ES (1) | ES416495A1 (xx) |
| FR (1) | FR2247241B1 (xx) |
| GB (1) | GB1383088A (xx) |
| HU (1) | HU168474B (xx) |
| IE (1) | IE37795B1 (xx) |
| IL (1) | IL42513A (xx) |
| LU (1) | LU67918A1 (xx) |
| NL (1) | NL7309226A (xx) |
| NO (1) | NO137899C (xx) |
| PH (1) | PH9997A (xx) |
| SE (1) | SE405477B (xx) |
| ZA (1) | ZA734041B (xx) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1433774A (en) * | 1973-02-26 | 1976-04-28 | Allen & Hanburys Ltd | Heterocyclic compounds apparatus for conveying articles |
| US4156726A (en) * | 1974-12-07 | 1979-05-29 | Fisons Limited | 4-Oxo-2-carboxyl quinoline derivatives used as antiallergic compounds |
| US4147694A (en) * | 1977-02-07 | 1979-04-03 | Riker Laboratories, Inc. | 8-(1H-Tetrazol-5-yl-carbamoyl)quinoline compounds |
| US4186201A (en) * | 1977-02-07 | 1980-01-29 | Riker Laboratories, Inc. | Methods of using 8(tetrazol-5-ylcarbamoyl)isoquinoline compounds |
| US4474792A (en) * | 1979-06-18 | 1984-10-02 | Riker Laboratories, Inc. | N-Tetrazolyl benzamides and anti-allergic use thereof |
| JPS56133284A (en) * | 1980-03-05 | 1981-10-19 | Glaxo Group Ltd | Amidotetrazole compound, manufacture and medicinal composition containing same |
| JPS61197558A (ja) * | 1985-02-25 | 1986-09-01 | Nippon Chemiphar Co Ltd | 新規なキナルジン酸アミド誘導体およびその製造法 |
| US4772703A (en) * | 1986-01-27 | 1988-09-20 | American Home Products Corporation | 2-(phenoxymethyl)-quinazolines as antiallergic and antiinflammatory agents |
| NZ234854A (en) * | 1989-08-11 | 1993-02-25 | Ici Plc | Quinoline derivatives, preparation, intermediates and pharmaceutical compositions thereof |
| US5028707A (en) * | 1989-11-20 | 1991-07-02 | Board Of Regents, University Of Texas | 4-hydroxyquinaldic acid derivatives |
| GB9010394D0 (en) * | 1990-05-09 | 1990-06-27 | Ici Plc | Heterocyclic compounds |
| US6340704B1 (en) | 1997-04-25 | 2002-01-22 | Takeda Chemical Industries, Ltd. | Cell differentiation inducing amide derivatives, their production and use |
| AU6593700A (en) * | 1999-08-18 | 2001-03-13 | Nippon Soda Co., Ltd. | Quinoline compounds and process for producing the same |
| FR2827599A1 (fr) * | 2001-07-20 | 2003-01-24 | Neuro3D | Composes derives de quinoleine et quinoxaline,preparation et utilisations |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3391146A (en) * | 1964-11-10 | 1968-07-02 | Bristol Myers Co | Nu-substituted carbamates and thiocarbamates of 2-quinolinemethanols |
-
1972
- 1972-07-03 GB GB3099072A patent/GB1383088A/en not_active Expired
-
1973
- 1973-06-14 IE IE978/73A patent/IE37795B1/xx unknown
- 1973-06-14 ZA ZA734041A patent/ZA734041B/xx unknown
- 1973-06-15 IL IL42513A patent/IL42513A/en unknown
- 1973-06-18 CS CS734384A patent/CS193474B2/cs unknown
- 1973-06-19 AU AU57099/73A patent/AU473752B2/en not_active Expired
- 1973-06-21 BE BE132551A patent/BE801246A/xx unknown
- 1973-06-21 HU HUAE386A patent/HU168474B/hu unknown
- 1973-06-21 US US05/372,027 patent/US3932416A/en not_active Expired - Lifetime
- 1973-06-25 CH CH920573A patent/CH592081A5/xx not_active IP Right Cessation
- 1973-06-26 SE SE7309000A patent/SE405477B/xx unknown
- 1973-06-27 DE DE2332731A patent/DE2332731A1/de active Pending
- 1973-06-28 AT AT570873A patent/AT328449B/de not_active IP Right Cessation
- 1973-07-02 PH PH14792A patent/PH9997A/en unknown
- 1973-07-02 ES ES416495A patent/ES416495A1/es not_active Expired
- 1973-07-02 LU LU67918A patent/LU67918A1/xx unknown
- 1973-07-02 NO NO2705/73A patent/NO137899C/no unknown
- 1973-07-03 NL NL7309226A patent/NL7309226A/xx not_active Application Discontinuation
- 1973-07-03 JP JP48075190A patent/JPS4962486A/ja active Pending
- 1973-07-03 FR FR7324350A patent/FR2247241B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| NO137899B (no) | 1978-02-06 |
| CH592081A5 (xx) | 1977-10-14 |
| GB1383088A (en) | 1975-02-05 |
| CS193474B2 (en) | 1979-10-31 |
| NL7309226A (xx) | 1974-01-07 |
| AU5709973A (en) | 1974-12-19 |
| FR2247241A1 (xx) | 1975-05-09 |
| FR2247241B1 (xx) | 1976-12-31 |
| US3932416A (en) | 1976-01-13 |
| BE801246A (fr) | 1973-12-21 |
| DE2332731A1 (de) | 1974-03-07 |
| PH9997A (en) | 1976-07-13 |
| IL42513A (en) | 1976-12-31 |
| JPS4962486A (xx) | 1974-06-17 |
| LU67918A1 (xx) | 1973-09-05 |
| IE37795B1 (en) | 1977-10-12 |
| AU473752B2 (en) | 1976-07-01 |
| IL42513A0 (en) | 1973-08-29 |
| ZA734041B (en) | 1974-05-29 |
| HU168474B (xx) | 1976-05-28 |
| IE37795L (en) | 1974-01-03 |
| NO137899C (no) | 1978-05-16 |
| ATA570873A (de) | 1975-06-15 |
| ES416495A1 (es) | 1976-06-01 |
| AT328449B (de) | 1976-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE393800B (sv) | Forfarande for framstellning av bensoylamino-alkyl-fenoxi-alkylkarbonsyraderivat med lipidsenkande effekt | |
| SE417205B (sv) | Forfarande for framstellning av foreningar med autibiotisk verkan | |
| SE398229B (sv) | Forfarande for framstellning av 4-fenoxi-fenoxialkankarbonsyraderivat | |
| SE385885B (sv) | Foerfarande foer framstaellning av 4-amino-6-arylpyrimidinderivat | |
| SE395149B (sv) | Forfarande for framstellning av dibenso-tiepinylpiperazinderivat | |
| SE403106B (sv) | Forfarande vid framstellning av 14-hydroximorfinanderivat | |
| SE405477B (sv) | Forfarande for framstellning av tetrazolyl-kinaldinsyraderivat med farmakologisk verkan | |
| SE401676B (sv) | Forfarande for framstellning av dibensofuranderivat | |
| SE380522B (sv) | Forfarande for framstellning av (1- (p-klorbensoyl)-5-metoxi-2-metyl-3-indol) - acetoxiettiksyra med antiflogistisk verkan | |
| SE385698B (sv) | Forfarande for framstellning av kinolinettiksyraderivat | |
| SE403911B (sv) | Forfarande for framstellning av aroylsubstituerade fenylettiksyraderivat med anti-inflammatorisk verkan | |
| SE389671B (sv) | Fforfarande for framstellning av 5-aroyl-pyrrolderivat med terapeutisk spec antiinflammatorisk verkan | |
| SE399708B (sv) | Forfarande for framstellning av tioxanton-2-karboxylsyraderivat | |
| SE401673B (sv) | Forfarande for framstellning av 2-substituerade 5-sulfamyl-bensoesyror med plasmalipidsenkande verkan | |
| SE7511680L (sv) | Forfarande for framstellning av furanderivat | |
| SE380273B (sv) | Forfarande for framstellning av tiopyrimidinderivat | |
| SE393801B (sv) | Forfarande for framstellning av tiokarbaminsyraderivat med antifungistatisk lekemedelsverken | |
| SE397827B (sv) | Forfarande for framstellning av 1-aminometyl-2,2-difenylcyklopropankarboxamidderivat med terapeutisk verkan | |
| SE384685B (sv) | Forfarande for framstellning av linkomycinderivat | |
| SE392722B (sv) | Forfarande for framstellning av oxazolidinderivat med terapeutisk verkan | |
| SE400278B (sv) | Forfarande for framstellning av fenylketonderivat | |
| SE380517B (sv) | Forfarande for framstellning av fluoren-2-ettiksyraderivat med antiinflammatorisk verkan | |
| SE389108B (sv) | Forfarande for framstellning av cyklopropylfenylpyrrolidinderivat med farmakologisk verkan | |
| SE409206B (sv) | Forfarande for framstellning av kinoxalindionderivat med hypnotisk verkan | |
| SE400287B (sv) | Forfarande for framstellning av fluorsubstituerade tiaxantenderivat |